In a new STAT commentary, Adam Marcus and Ivan Oransky of Retraction Watch argue that the American Diabetes Association is not showing the same resolve they once admired. The writers point back to a column from nine years ago, when they praised the ADA for standing up to a researcher in Brazil who had sued the organization in U.S. federal court.
Their latest piece says that earlier image of the ADA as a principled institution no longer holds. While the trimmed excerpt does not include the full details behind their criticism, the headline and description make clear that the authors now see the group as falling short of the kind of courage they previously credited it with.
The commentary appears to center on a broader concern about research oversight and institutional accountability. By contrasting the ADA’s past response in a legal fight with its present behavior, Marcus and Oransky frame the issue as more than a single dispute, suggesting a change in how the organization handles challenges tied to scientific standards.
The article adds to ongoing debate over how major health associations should respond when questions arise around researchers, publications, and integrity. For readers following the American Diabetes Association, the piece presents a sharp reassessment from two media critics who once held the group up as an example of backbone under pressure.
